ʻO ka weheweheʻana
ʻO kā mākou mea i hoʻopiliʻia i loko o nā'ōnaehana hana ma ka hana hana e hana ai i ka toricitinib, kahi lāʻau lapaʻau maikaʻi i hoʻohanaʻia e mālama i kekahi mauʻano o ka'ōpū. ʻO kēia mau mea pāʻani ma waena o kahi hana koʻikoʻi ma ka hanaʻana o ka toricacitinib, ke hāʻawi nei i kona kūpono a me ka maikaʻi. Via (2R, 3r) -2,3-bis [(4-Materylbenzyzyl)
ʻO kaʻano molela a me ke kaumaha o kā mākou mea e hōʻike ai i ka waena waena o ka manematika a me ka paleʻana, e hana ana i kahi hana kūpono o ka hale kūʻai lāʻau lapaʻau. Me nā mea i koiʻia me kona mau mea i hōʻoiaʻia,ʻo kēia ka mea i hōʻoia i ka waena a me ka hopena o ka huahana hope loa, tfacitinib. ʻO kāna mau molecular i hāʻawiʻia e hāʻawiʻia i ka hana holoʻokoʻa a me ke ola a me ke olaʻana, e hōʻoiaʻiʻo ana i ka hopena a hilinaʻi i ka lōʻihi.
Koho iā mākou
ʻO Jdk i nā hale hana mua o nā papa mua a me nā mea hoʻokele waiwai kūpono, e hōʻoia ana i ka nui o ka pono o ka API i kauʻia. ʻO ka hui loea e hoʻopiʻi iā R & D o ka huahana. E kū'ē iā lāua, keʻimi nei mākou no CMM & CDMO ma ka hale kūʻai home a me ka mākeke honua.